156 related articles for article (PubMed ID: 27491505)
21. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation.
Kagan KO; Valencia C; Livanos P; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jan; 33(1):18-22. PubMed ID: 19031473
[TBL] [Abstract][Full Text] [Related]
22. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects.
Chelemen T; Syngelaki A; Maiz N; Allan L; Nicolaides KH
Fetal Diagn Ther; 2011; 29(2):127-34. PubMed ID: 21160164
[TBL] [Abstract][Full Text] [Related]
23. The role of ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during the first trimester of pregnancy.
Florjański J; Fuchs T; Zimmer M; Homola W; Pomorski M; Blok D
Adv Clin Exp Med; 2013; 22(3):395-401. PubMed ID: 23828681
[TBL] [Abstract][Full Text] [Related]
24. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
[TBL] [Abstract][Full Text] [Related]
25. First-trimester ductus venosus screening for cardiac defects: a meta-analysis.
Papatheodorou SI; Evangelou E; Makrydimas G; Ioannidis JP
BJOG; 2011 Nov; 118(12):1438-45. PubMed ID: 21668765
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and outcome of absence of ductus venosus at 11(+0) to 13(+6) weeks.
Staboulidou I; Pereira S; Cruz Jde J; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2011; 30(1):35-40. PubMed ID: 21335936
[TBL] [Abstract][Full Text] [Related]
27. First trimester ultrasound screening for Down syndrome based on maternal age, fetal nuchal translucency and different combinations of the additional markers nasal bone, tricuspid and ductus venosus flow.
Abele H; Wagner P; Sonek J; Hoopmann M; Brucker S; Artunc-Ulkumen B; Kagan KO
Prenat Diagn; 2015 Dec; 35(12):1182-6. PubMed ID: 26223508
[TBL] [Abstract][Full Text] [Related]
28. [Screening performance of first trimester nuchal translucency, ductus venosus blood flow and tricuspid regurgitation for cardiac defects].
Geipel A; Gembruch U
Z Geburtshilfe Neonatol; 2012 Aug; 216(4):157-61. PubMed ID: 22926815
[TBL] [Abstract][Full Text] [Related]
29. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
30. Association of first trimester fetal heart rate and nuchal translucency with preterm birth.
Morales-Roselló J; Loscalzo G; Perez G; Payá AS; Jakaitė V; Perales-Marín A
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5572-5579. PubMed ID: 33618603
[TBL] [Abstract][Full Text] [Related]
31. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
32. Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?
Prats P; Ferrer Q; Comas C; Rodríguez I
Fetal Diagn Ther; 2012; 32(1-2):138-43. PubMed ID: 22585666
[TBL] [Abstract][Full Text] [Related]
33. [Birth defects associated with increased nuchal translucency].
Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
[TBL] [Abstract][Full Text] [Related]
34. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.
Kagan KO; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):42-7. PubMed ID: 25307357
[TBL] [Abstract][Full Text] [Related]
35. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
36. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027
[TBL] [Abstract][Full Text] [Related]
37. Prenatal diagnosis of Turner syndrome: report on 69 cases.
Papp C; Beke A; Mezei G; Szigeti Z; Bán Z; Papp Z
J Ultrasound Med; 2006 Jun; 25(6):711-7; quiz 718-20. PubMed ID: 16731887
[TBL] [Abstract][Full Text] [Related]
38. Detection of congenital heart defects throughout pregnancy; impact of first trimester ultrasound screening for cardiac abnormalities.
Eleftheriades M; Tsapakis E; Sotiriadis A; Manolakos E; Hassiakos D; Botsis D
J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2546-50. PubMed ID: 22712625
[TBL] [Abstract][Full Text] [Related]
39. Abnormal ductus venosus flow and tricuspid regurgitation at 11-14 weeks' gestation have high positive predictive values for increased risk in first-trimester combined screening test: results of a pilot study.
Ozkaya O; Sezik M; Ozbasar D; Kaya H
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):145-50. PubMed ID: 20708518
[TBL] [Abstract][Full Text] [Related]
40. First-Trimester Nonvisualization of the Parotid Gland and Aneuploidy in Fetuses With Increased Nuchal Translucency: A Prospective Cohort Study.
Perlman S; Sukenik-Helevy R; Odeh M; Keren Gilat E; Gilboa Y
J Ultrasound Med; 2021 Jan; 40(1):41-47. PubMed ID: 32946138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
